The discovery of a unique ratio of metabolites in blood samples taken from early-stage Alzheimer's patients could be a critical new biomarker for early detection of the neurodegenerative disease.
The discovery of a unique ratio of metabolites in blood samples taken from early-stage Alzheimer's patients could be a critical new biomarker for early detection of the neurodegenerative disease.
Share this Article
Recommended